Kenya Bets On Single-Doze HPV Vaccine in Cervical Cancer War

Nairobi — Kenya is switching to a single-dose Human Papillomavirus (HPV) vaccine in a bold move aimed at eliminating cervical cancer and boosting access for girls aged 10 to 14 years.

The shift — announced by the Ministry of Health during the Coalition to Strengthen HPV Immunization Community (CHIC) symposium in Nairobi — follows recommendations from the National Immunization Technical Advisory Group (KENITAG), which confirmed that one dose provides the same robust protection as multiple…